Evidence map›Paper›PMID 38559352›Full record

ArticleFrontiers in microbiology2024

Prasanth Manohar, Belinda Loh, Dann Turner, Ramasamy Tamizhselvi, Marimuthu Mathankumar, Namasivayam Elangovan, Ramesh Nachimuthu, Sebastian Leptihn

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. UnderstandingMicroorganisms · 2026
    Review
  2. Review
  3. Isolation and characterization of a lytic phage and its efficacy against multi-drug resistant strains of pseudomonas aeruginosa.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Characterisation of a NovelPathogens (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. A biofilm-tropiceLife · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Prasanth Manohar *School of Bioscience and Technology, Vellore Institute of Technology (VIT), Vellore, India.
Belinda LohDepartment of Vaccines and Infection Models, Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany.
Dann TurnerSchool of Applied Sciences, College of Health, Science and Society, University of the West of England, Bristol, United Kingdom.
Ramasamy TamizhselviSchool of Bioscience and Technology, Vellore Institute of Technology (VIT), Vellore, India.
Marimuthu MathankumarSchool of Bioscience and Technology, Vellore Institute of Technology (VIT), Vellore, India.
Namasivayam ElangovanDepartment of Biotechnology, School of Bioscience, Periyar University, Salem, Tamil Nadu, India.
Ramesh NachimuthuSchool of Bioscience and Technology, Vellore Institute of Technology (VIT), Vellore, India.
Sebastian LeptihnDepartment of Biochemistry, Health and Medical University, Erfurt, Germany.
Vellore Institute of Technology University · INFraunhofer Institute for Cell Therapy and Immunology · DEPeriyar University · INUniversity of Erfurt · DEUniversity of the West of England · GB

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
NIH HHS P40 OD010440
6 · The paper itself

Abstract

Infections caused by

Indexed as

anti-biofilm activitybacteriophagesCaenorhabditis elegansphage-mammalian cell interactionphage therapyPseudomonas aeruginosa

Identifiers

PMID38559352
PMCPMC10978715
OpenAlexW4392859390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.